EFFECT OF NON PHARMACOLOGICAL INTERVENTION ON DIABETIC COMPLICATION IN PATIENT WITH TYPE 2 DIABETES MELLITUS: A SYSTEMATIC REVIEW
DOI:
https://doi.org/10.53555/nnmhs.v8i12.1465Keywords:
Complication, Diabetes Mellitus, Lifestyle, Non-pharmacologycalAbstract
Because of this, doctors and other healthcare professionals face the challenge of treating a significant number of diabetic patients in their day-to-day clinical practice. Because of this, it is imperative for them to be equipped with the knowledge and skills necessary to deal with situations such as these. Type 1 diabetes mellitus, commonly known as T1DM, and type 2 diabetes mellitus are the most prevalent kinds of diabetes that are diagnosed in clinical settings. Other forms of diabetes, such as gestational diabetes, are less common (also known as T2DM). Nevertheless, there is a very small percentage of people who also suffer from other forms of diabetes. Some of the lifestyle changes that are believed to be helpful in preventing type 2 diabetes mellitus or delaying the onset of the condition include eating a healthy, well-balanced diet, keeping a healthy body weight, engaging in regular physical activity, breaking the habit of leading a sedentary lifestyle, and staying away from tobacco use. Findings from the Diabetes Prevention Program (DPP) suggest that obtaining and keeping a healthy weight is one of the most essential things that can be done to lower one's risk of acquiring diabetes. Patients diagnosed with diabetes mellitus have access to a variety of non-pharmacological intervention strategies, including changes in their diet and lifestyle, which can be used to help reduce the risk of diabetic complications. The patient education that is provided can also be incorporated into reminders for the patient.
References
International Diabetes Federation. Diabetes. Brussels: IDF; 2017.
Pappachan JM, Fernandez CJ, Chacko EC. Diabesity and antidiabetic drugs. Mol Aspects Med. April 2019;66:3–12.
Fauci AS, Jameson JL, Kasper D, et al. Harrison’s Principles of Internal Medicine 19th Edition. New York: McGraw-Hill Education; 2018.
American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2016;62–9.
World Health Organization (WHO). Classification of Diabetes Mellitus 2019. Geneva: World Health Organization; 2019.
Raveendran A V, Chacko EC, Pappachan JM. Non-pharmacological Treatment Options in the Management of Diabetes Mellitus. Eur Endocrinol. September 2018;14(2):31–9.
Zhou R, Cui Y, Zhang Y, De J, An X, Duan Y, et al. The Long-Term Effects of Non-Pharmacological Interventions on Diabetes and Chronic Complication Outcomes in Patients With Hyperglycemia: A Systematic Review and Meta-Analysis [Internet]. Vol. 13, Frontiers in Endocrinology . 2022. Tersedia pada: https://www.frontiersin.org/articles/10.3389/fendo.2022.838224
Aro A, Kauppinen A, Kivinen N, Selander T, Kinnunen K, Tuomilehto J, et al. Life Style Intervention Improves Retinopathy Status-The Finnish Diabetes Prevention Study. Nutrients. Juli 2019;11(7).
Ramachandran A, Snehalatha C, Ram J, Selvam S, Simon M, Nanditha A, et al. Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel-group, randomised controlled trial. lancet Diabetes Endocrinol. November 2013;1(3):191–8.
Nanditha A, Snehalatha C, Raghavan A, Vinitha R, Satheesh K, Susairaj P, et al. The post-trial analysis of the Indian SMS diabetes prevention study shows persistent beneficial effects of lifestyle intervention. Diabetes Res Clin Pract. Agustus 2018;142:213–21.
Davies MJ, Gray LJ, Troughton J, Gray A, Tuomilehto J, Farooqi A, et al. A community based primary prevention programme for type 2 diabetes integrating identification and lifestyle intervention for prevention: the Let’s Prevent Diabetes cluster randomised controlled trial. Prev Med (Baltim). 2016;84:48–56.
Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. lancet Diabetes Endocrinol. November 2015;3(11):866–75.
Roglic G. WHO Global report on diabetes: A summary. Int J Noncommunicable Dis. 2016;1(1):3.
Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. Mei 2001;344(18):1343–50.
Chen Y, Zhang P, Wang J, Gong Q, An Y, Qian X, et al. Associations of progression to diabetes and regression to normal glucose tolerance with development of cardiovascular and microvascular disease among people with impaired glucose tolerance: a secondary analysis of the 30 year Da Qing Diabetes Prevention Outcome Study. Diabetologia. Juni 2021;64(6):1279–87.
van Leiden HA, Dekker JM, Moll AC, Nijpels G, Heine RJ, Bouter LM, et al. Blood pressure, lipids, and obesity are associated with retinopathy: the hoorn study. Diabetes Care. Agustus 2002;25(8):1320–5.
Orchard TJ, Temprosa M, Goldberg R, Haffner S, Ratner R, Marcovina S, et al. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann Intern Med. 2005;142(8):611–9.
Brown JS, Wing R, Barrett-Connor E, Nyberg LM, Kusek JW, Orchard TJ, et al. Lifestyle intervention is associated with lower prevalence of urinary incontinence: the Diabetes Prevention Program. Diabetes Care. 2006;29(2):385–90.
Florez H, Pan Q, Ackermann RT, Marrero DG, Barrett-Connor E, Delahanty L, et al. Impact of lifestyle intervention and metformin on health-related quality of life: the diabetes prevention program randomized trial. J Gen Intern Med. 2012;27(12):1594–601.
Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet. 2008;371(9626):1783–9.
Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, Brenneman AT, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet (London, England). 2009;374(9702):1677–86.
Hamman RF, Wing RR, Edelstein SL, Lachin JM, Bray GA, Delahanty L, et al. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care. 2006;29(9):2102–7.
Pan X-R, Li G, Hu Y-H, Wang J-X, Yang W-Y, An Z-X, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20(4):537–44.
Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, Hsu RT, et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. Bmj. 2007;334(7588):299.
Rawal LB, Tapp RJ, Williams ED, Chan C, Yasin S, Oldenburg B. Prevention of type 2 diabetes and its complications in developing countries: a review. Int J Behav Med. 2012;19(2):121–33.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Journal of Advance Research in Medical & Health Science
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
